|
Discussion Agenda:
|
-
Performance of the Indian Pharmaceutical Industry during YTD FY 2019 and outlook for FY 2020
-
Impact of recent price control orders by National Pharmaceutical Pricing Authority (NPPA) and US pricing pressure on Indian Pharmaceutical Industry
|
|
|
|
Mr. Subrata Ray
Senior Group Vice President
ICRA Limited
|
|
Mr. Gaurav Jain
Vice President
ICRA Limited
|
| |
|
|
|
|
Ms. Kinjal Shah
Vice President
ICRA Limited
|
| |
|
|
|
|
|
|
